ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...
Johnson & Johnson has announced more than $1 billion investment in a next generation cell therapy manufacturing faci...
After talks between India's Union Minister for Science and Technology (S&T) Dr Jitendra Singh and Australian&nb...
AusBiotech and Sydney‑based life sciences company creator Proto Axiom have signed a Memorandum of Understanding ...
The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...
CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...
Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...
Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening...
Budapest-based Gedeon Richter Plc. and Japan's Fuji Pharma Co. have announced the expansion and further strengthening of...
A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-res...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.39 b...
South Korea-based SK bioscience will advance a novel respiratory syncytial virus (RSV) monoclonal antibody (mAb) for glo...
Australia-based startup AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha the...
Researchers have opened a ‘window to the brain’ with a new diagnostic device that can tell how deadly brain ...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (I...
The Asian biopharma landscape is evolving rapidly and undergoing major shifts, expanding focus beyond generics and contr...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinica...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Dr. Peiqing Zhang, Scientific Director, Cytiva (Left) Dr. Timothy Tan, Associate Professor and Leading Investigator, NT...
To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors...
AusBiotech welcomes the Australian Government's announcement, made by the Minister for Trade and Tourism, Senator the Do...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of d...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
Japan-based PRISM BioLab and US-based startup Talus Bioscience, Inc. have entered into a collaboration to discover novel...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Galux, a South Korean biotech startup pioneering AI-driven protein therapeutics discovery, has signed a research agreeme...
MEDI&GENE, a South Korea-based biopharmaceutical company developing therapeutics for metabolic diseases, has entered...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
ADEL, Inc., a South Korea-based biopharmaceutical company dedicated to developing therapies for neurodegenerative diseas...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
Japan-based Chugai Pharmaceutical has announced the establishment of a new partnering office in South San Francisco, US....
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
Vietnam’s burgeoning tech ecosystem is poised to ignite a vibrant new era of cross-continental collaboration and i...
Singapore-based NUS Medicine’s Clinical Imaging Research Centre (CIRC), a leading academic centre for advanced mol...
The Research, Innovation and Enterprise 2030 (RIE2030) plan was endorsed at the 15th Research, Innovation and Enterprise...
Taiwan-based Jyong Biotech, specialising in the treatment of urinary system diseases, with an initial focus on the marke...
Leading scientific organisations in Korea including the Korea Disease Control Agency (KDCA), International Vaccine Insti...
Agilent Technologies Inc. has announced the expansion of their strategic collaboration with Monash University&...
Biosparc’s landmark project in Suzhou Industrial Park reached structural completion. On 20 November 2025 the firm ...
Thermo Fisher Scientific Inc., the world leader in serving science, announced an expansion of its bioprocessing capabili...
Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...
It has been over a year since you took on the role of CEO at AusBiotech. What have been your key priorities so far, and ...
Your recent Singapore survey highlights persistent vaccine hesitancy among older adults, with only 51 per cent willing t...
China has reached a major milestone in global pharmaceutical innovation. According to the latest report from Clarivate, ...
The Asia-Pacific biotech sector is entering 2026 with renewed momentum. Investment in the pre-clinical organoid space co...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
Australia's Imugene has entered a strategic co-development collaboration with Chinese startup JW Therapeutics to evaluat...
SK Biopharmaceuticals, a South Korea-based biotech company specialising in research, development, and commercialisation ...
Jyong Biotech, a science-driven biotechnology company based in Taiwan committed to developing and commercialising innova...
3D printed blood vessels on glass that mimic blood vessel anatomy and the fluid dynamics of blood flow could be an inval...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
CytoMed Therapeutics, a Singapore-based clinical stage biopharmaceutical startup focused on harnessing its proprietary n...
King Abdullah International Medical Research Center (KAIMRC), the largest medical research institution in the Kingdom of...
Hong Kong's BIOVOZ has announced a strategic research partnership with the University of Auckland, New Zealand marking a...
MedTech firms BD Medical Products and Terumo Asia Holdings have come on board to strengthen Duke-NUS Medical School&rsqu...
As a key step in Bayer’s “In China, for Global” strategy, the Bayer E-Town Open Innovation Center offi...
South Korea-based ABL Bio, a company specializing in bispecific antibodies, has entered license, research and collaborat...
Australia’s new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, has been l...
ImmunoScape, an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer im...
Australia's Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step towa...
Vaxcellbio, a South Korea-based immuno-oncology company, has entered into a strategic Memorandum of Understanding (MoU) ...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Puerto Rico’s transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum...
China-based startups Sanyou Bio and Yugong Bio have announced the signing of a strategic cooperation agre...
South Korea-based Samsung Epis Holdings Co. has announced the establishment of Epis NexLab Co., a new subsidiary that wi...
One of Australia’s newest Australian Research Council (ARC) Training Centres is preparing researchers to lead in n...
Onward Therapeutics has announced the completion of a share exchange, under which Onward Therapeutics, Inc. (Onward Taiw...
4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise ...
TechInnovation 2025 concluded on an inspiring note as leaders from long-standing industries shared how they are transfor...
Vietnam’s pharmaceutical market is expanding rapidly. According to Fitch Solutions, it was valued at $6 billion in...
TechInnovation 2025, organised by IPI Singapore, continued to Day 2 at Sands Expo & Convention Centre, Level 3,...
